Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
PMID: 15817669
By: Mike Montemarano Associate Editor, Nutraceuticals World An ongoing NIH-funded study which will be published in the Annals of Medicine and Surgery Journal, is investigating the outcomes in patients suffering from heart failure with preserved ejection fraction (HFpEF) who are supplementing with a either combination of CoQ10 in the form of ubiquinol and D-ribose, a simple sugar from which RNA is built, only one of the ingredients, or placebo
Tsukuda, Journal of the American Chemical Society 127, (2005) 52615270
Information is presented for scientific reference and laboratory applications only
This is wellness and antioxidant support, not a medical or cosmetic procedure, and results build gradually with consistency rather than appearing overnight
Navigating the Choice: Considerations for Your Lab When faced with the decision of KLOW vs KPV, our team recommends a thorough review of your experimental design and desired endpoints
US$ 26.66
US$ 20.11
US$ 22.76
US$ 23.29
US$ 22.98
US$ 20.75
